Anderson Hoagland & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.37M Sell
21,155
-157
-0.7% -$36.6K 0.42% 61
2026
Q1
$5.21M Sell
21,312
-43
-0.2% -$10K 0.45% 61
2025
Q4
$4.42M Buy
21,355
+157
+0.7% +$31K 0.38% 70
2025
Q3
$3.93M Sell
21,198
-45
-0.2% -$7.71K 0.35% 72
2025
Q2
$3.24M Buy
21,243
+5,648
+36% +$868K 0.31% 79
2025
Q1
$2.34M Sell
15,595
-24
-0.2% -$3.75K 0.28% 87
2024
Q4
$2.3M Hold
15,619
0.24% 92
2024
Q3
$2.5M Hold
15,619
0.26% 91
2024
Q2
$2.3M Buy
+15,619
New +$2.32M 0.24% 94
2017
Q2
Sell
-22,605
Closed -$2.81M 102
2017
Q1
$2.81M Sell
22,605
-510
-2% -$60.9K 1.52% 14
2016
Q4
$2.66M Sell
23,115
-1,748
-7% -$202K 1.55% 19
2016
Q3
$2.94M Buy
24,863
+21,552
+651% +$2.61M 1.69% 14
2016
Q2
$402K Sell
3,311
-14
-0.4% -$1.59K 0.25% 87
2016
Q1
$360K Buy
+3,325
New +$344K 0.22% 86

Other funds holding JNJ

Anderson Hoagland & Co's JNJ Position: Q2 2026 in Review

Anderson Hoagland & Co reduced its Johnson & Johnson (JNJ) stake by 0.74% in Q2 2026, selling an estimated $36.6K and leaving 21,155 shares worth $5.37M. The position accounts for 0.42% of the portfolio, ranked #61.

Anderson Hoagland & Co first reported a position in JNJ in Q1 2016 and has held it in 14 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Anderson Hoagland & Co held 21,155 shares of Johnson & Johnson worth $5.37M as of Q2 2026.
  • Anderson Hoagland & Co sold 157 Johnson & Johnson shares in Q2 2026, an estimated $36.6K.
  • Johnson & Johnson made up 0.42% of Anderson Hoagland & Co's portfolio in Q2 2026, its #61 holding.
  • Anderson Hoagland & Co first reported a position in Johnson & Johnson in Q1 2016 and has held it in 14 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Anderson Hoagland & Co's 13F filing for Q2 2026, filed 6 Jul 2026.